🚨 Pulmonary embolism
Pulmonary embolism is often called the ‘great masquerader’ of emergency medicine. It can mimic pneumonia, acute coronary syndrome, heart failure, COPD exacerbation, anxiety, or even syncope. The key to diagnosis is applying the right test to the right patient using validated clinical prediction tools, here’s the brief & concise notes about PE.
#MedX #NEETPG
Chronic kidney disease (#CKD) affects 788–844 million adults worldwide — and is projected to become the fifth leading cause of death by 2040.
A Lancet Series examines what is needed to change this trajectory: https://t.co/JszuVGJljc @ERAkidney#ERA2026
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal.
Read the Review Article “GLP-1 Receptor Agonists” by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, from @tuftsmedschool and the Maine Medical Center Institute for Research: https://t.co/D0XSLv7U8n
The SURMOUNT-MMO trial is underway to test if #tirzepatide can reduce heart attacks, strokes, heart failure, and death in adults with obesity. This global study will enroll ~15,000 people at risk for cardiovascular events and is the first trial to see if an incretin medication can prevent both primary & secondary CV events in this population.
https://t.co/CdM33IADAT